Svikle Zane, Pahirko Leonora, Zariņa Līga, Baumane Kristīne, Kardonaite Deimante, Radzeviciene Lina, Daugintyte-Petrusiene Laura, Balciuniene Vilma Jurate, Verkauskiene Rasa, Tiščuka Angeļina, Rovite Vita, Sjakste Nikolajs, Sokolovska Jelizaveta
Faculty of Medicine, University of Latvia, Jelgavas Street 3, LV 1004 Riga, Latvia.
Faculty of Physics, Mathematics and Optometry, University of Latvia, Jelgavas Street 3, LV 1004 Riga, Latvia.
J Clin Med. 2022 May 13;11(10):2768. doi: 10.3390/jcm11102768.
The aim of the study was to compare telomere lengths and circulating proteasome concentrations in patients with different stages of diabetic retinopathy and type 1 diabetes in Latvia and Lithuania. Methods. Patients with no diabetic retinopathy and with non-proliferative diabetic retinopathy were included in the NDR/NPDR group (n = 187). Patients with proliferative diabetic retinopathy and status post laser-photocoagulation were included int the PDR/LPC group (n = 119). Telomeres were evaluated by real-time quantitative polymerase chain reaction. Proteasome concentration was measured by ELISA. Results. Telomeres were longer in PDR/LPC (ΔCT 0.21 (0.12−0.28)) vs. NDR/NPDR (ΔCT 0.18 (0.1−0.28)), p = 0.036. In NDR/NPDR, telomeres were correlated negatively with age (R = −0.17, p = 0.019), BMI (R = −0.21, p = 0.004), waist/hip ratio (R = −0.21, p = 0.005), total cholesterol (R = −0.18, p = 0.021), and low-density cholesterol (R = −0.20, p = 0.010), and positively with estimated glomerular filtration rate (eGFR) (R = 0.28, p < 0.001). None of the above correlations were observed in PRD/LPC. Proteasome concentrations were lower in PDR/LPC (130 (90−210) ng/mL) vs. NDR/NPDR (150 (100−240) ng/mL), p = 0.024. This correlated negatively with eGFR (R = −0.17, p = 0.025) in the NDR/NPDR group and positively with age (R = 0.23, p = 0.014) and systolic blood pressure (R = 0.20, p = 0.032) in the PRD/LPC group. Telomere lengths did not correlate with proteasome concentrations. Conclusion. Longer telomeres and lower circulating proteasome concentrations are observed in patients with type 1 diabetes and advanced diabetic retinopathy.
该研究旨在比较拉脱维亚和立陶宛不同阶段糖尿病视网膜病变及1型糖尿病患者的端粒长度和循环蛋白酶体浓度。方法。无糖尿病视网膜病变和非增殖性糖尿病视网膜病变患者纳入非糖尿病视网膜病变/非增殖性糖尿病视网膜病变组(n = 187)。增殖性糖尿病视网膜病变及激光光凝术后患者纳入增殖性糖尿病视网膜病变/激光光凝术后组(n = 119)。通过实时定量聚合酶链反应评估端粒。采用酶联免疫吸附测定法测量蛋白酶体浓度。结果。增殖性糖尿病视网膜病变/激光光凝术后组的端粒更长(ΔCT 0.21(0.12 - 0.28)),而非糖尿病视网膜病变/非增殖性糖尿病视网膜病变组为(ΔCT 0.18(0.1 - 0.28)),p = 0.036。在非糖尿病视网膜病变/非增殖性糖尿病视网膜病变组中,端粒与年龄(R = -0.17,p = 0.019)、体重指数(R = -0.21,p = 0.004)、腰臀比(R = -0.21,p = 0.005)、总胆固醇(R = -0.18,p = 0.021)和低密度胆固醇(R = -0.20,p = 0.010)呈负相关,与估计肾小球滤过率(eGFR)呈正相关(R = 0.28,p < 0.001)。在增殖性糖尿病视网膜病变/激光光凝术后组未观察到上述任何相关性。增殖性糖尿病视网膜病变/激光光凝术后组的蛋白酶体浓度较低(130(90 - 210)ng/mL),而非糖尿病视网膜病变/非增殖性糖尿病视网膜病变组为(150(100 - 240)ng/mL),p = 0.024。在非糖尿病视网膜病变/非增殖性糖尿病视网膜病变组中,这与eGFR呈负相关(R = -0.17,p = 0.025),在增殖性糖尿病视网膜病变/激光光凝术后组中与年龄呈正相关(R = 0.23,p = 0.014)和收缩压呈正相关(R = 0.20,p = 0.032)。端粒长度与蛋白酶体浓度无相关性。结论。1型糖尿病和晚期糖尿病视网膜病变患者存在更长的端粒和更低的循环蛋白酶体浓度。